June 22, 2023

The June 2023 test bulletin brings several updates. Alverno Laboratories has revised their Precision Medicine and Hematopathology forms on their website. UroVysion FISH testing will now be outsourced to Quest Diagnostics. Quantitative PCR measurements for CMV will transition to the Abbott Alinity m platform. Omadacycline susceptibility testing is now available. Additionally, E. coli O157 microbiological culture identification will be discontinued in favor of Shiga toxin detection methods. Prenatal testing submissions to Quest Diagnostics require the Maternal Screening Form. Lastly, there are changes in specimen requirements for Non-Respiratory Viral Culture testing sent to Quest Diagnostics.